Consainsights logo
Reports / Antacids Market

Antacids Market

Antacids Market Research Report – Segmented By Formulation Type (Others, Powder, Tablet), Distribution Channel (E-Commerce, Hospital Pharmacies, Others) & Region (North America, Europe, APAC, Latin America, Middle East and Africa) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2017 to 2026.


01

Executive Summary

Antacids Market was valued at US $6.62 billion in 2021 and is projected to grow at 4.22% CAGR over the forecast period to reach US $8.48 billion by 2027. Antacids Market represented US $0.52 billion opportunity over 2019-2021 and estimated to create US $1.86 billion opportunity in 2027 over 2021.

Antacids from Consainsights analyses the Antacids Market in the Life Sciences industry over the forecast period to 2027.

Antacids research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Antacids segmentation includes Formulation Type, Distribution Channel and Geography.

Based on the Formulation Type, the Antacids analysis covers Tablet, Powder, Others.

In Formulation Type segment, Tablet segment has highest cagr growth of 3.74%.

Based on the Distribution Channel, the Antacids analysis covers Hospital Pharmacies, E-Commerce, Others.

In Distribution Channel segment, Hospital Pharmacies segment has highest cagr growth of 3.74%.

Based on the region, the Antacids analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Bayer AG, GlaxoSmithKline PLC, Johnson & Johnson, Sun Pharmaceuticals Ltd, Sanofi S.A, WellSpring Pharmaceutical Corporation, Advance Pharmaceutical Inc., CVS Pharmacy, Safetec of America, Inc., Pfizer inc., Boehringer Ingelheim International GmbH, Dr. Reddy's Laboratories Ltd., Reckitt Benckiser Group plc., Takeda Pharmaceutical Company Limited, Procter & Gamble and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

  • Revenue Share (%), By Formulation Type (2021)
    Revenue Share (%), By Formulation Type (2021)
  • Revenue Share (%), By Distribution Channel (2021)
    Revenue Share (%), By Distribution Channel (2021)
02

Market Overview

  • The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.
  • The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.
  • The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.
  • Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.
  • Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.
  • As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.
  • The currency used in this report is USD, with the market size indicated in terms of USD million/billion.
  • For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.
  • For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.
03

By Formulation Type

  • Tablet accounted for US$4.76 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Powder accounted for US$1.78 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Others accounted for US$0.08 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Antacids Market Y-o-Y Growth (USD billion), By Formulation Type 2019 - 2027
Antacids Market Y-o-Y Growth (USD billion), By Formulation Type 2019 - 2027
Antacids Market Size, By Formulation Type, 2019-2027 (USD billion)
Antacids Market Size, By Formulation Type, 2019-2027 (USD billion)

The Others segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Others: global Antacids Market Revenue Opportunity (Us$ Mn)
Others: global Antacids Market Revenue Opportunity (Us$ Mn)

The Powder segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Powder: global Antacids Market Revenue Opportunity (Us$ Mn)
Powder: global Antacids Market Revenue Opportunity (Us$ Mn)

The Tablet segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Tablet: global Antacids Market Revenue Opportunity (Us$ Mn)
Tablet: global Antacids Market Revenue Opportunity (Us$ Mn)
04

By Distribution Channel

  • Hospital Pharmacies accounted for US$2.52 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • E-Commerce accounted for US$2.47 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Others accounted for US$1.63 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Antacids Market Y-o-Y Growth (USD billion), By Distribution Channel 2019 - 2027
Antacids Market Y-o-Y Growth (USD billion), By Distribution Channel 2019 - 2027
Antacids Market Size, By Distribution Channel, 2019-2027 (USD billion)
Antacids Market Size, By Distribution Channel, 2019-2027 (USD billion)

The E-Commerce segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

E-Commerce: global Antacids Market Revenue Opportunity (Us$ Mn)
E-Commerce: global Antacids Market Revenue Opportunity (Us$ Mn)

The Hospital Pharmacies segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Hospital Pharmacies: global Antacids Market Revenue Opportunity (Us$ Mn)
Hospital Pharmacies: global Antacids Market Revenue Opportunity (Us$ Mn)

The Others segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

Others: global Antacids Market Revenue Opportunity (Us$ Mn)
Others: global Antacids Market Revenue Opportunity (Us$ Mn)
05

North America

  • In 2021, North America segment accounted for US$6.62 Bn and is expected grow with a CAGR of 4.22% over the forecast years.
  • In North America, United States accounted for US$4.20 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Canada accounted for US$2.42 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
North America Antacids Market, By Country, 2019-2027 (USD billion)
North America Antacids Market, By Country, 2019-2027 (USD billion)
North America Antacids Market - Market Opportunity (USD billion), 2019, 2021 & 2027
North America Antacids Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Revenue Share (%), By Formulation Type - North America (2021)
Revenue Share (%), By Formulation Type - North America (2021)
Revenue Share (%), By Distribution Channel - North America (2021)
Revenue Share (%), By Distribution Channel - North America (2021)
North America Antacids Market, By Country, 2019-2027 (USD billion)
North America Antacids Market, By Country, 2019-2027 (USD billion)
United States Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
United States Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
United States Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
United States Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Canada Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Canada Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Canada Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Canada Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
06

Europe

  • In 2021, Europe segment accounted for US$6.62 Bn and is expected grow with a CAGR of 4.22% over the forecast years.
  • In Europe, Germany accounted for US$2.51 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • United Kingdom accounted for US$1.68 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • France accounted for US$1.07 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Spain accounted for US$0.73 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Russia accounted for US$0.26 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Italy accounted for US$0.35 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Rest of Europe accounted for US$0.03 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Europe Antacids Market, By Country, 2019-2027 (USD billion)
Europe Antacids Market, By Country, 2019-2027 (USD billion)
Europe Antacids Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Europe Antacids Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Revenue Share (%), By Formulation Type - Europe (2021)
Revenue Share (%), By Formulation Type - Europe (2021)
Revenue Share (%), By Distribution Channel - Europe (2021)
Revenue Share (%), By Distribution Channel - Europe (2021)
Europe Antacids Market, By Country, 2019-2027 (USD billion)
Europe Antacids Market, By Country, 2019-2027 (USD billion)
Germany Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Germany Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Germany Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Germany Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
United Kingdom Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
United Kingdom Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
United Kingdom Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
United Kingdom Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
France Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
France Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
France Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
France Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Spain Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Spain Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Spain Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Spain Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Russia Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Russia Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Russia Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Russia Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Italy Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Italy Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Italy Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Italy Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Rest of Europe Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Rest of Europe Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Rest of Europe Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Rest of Europe Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
07

Asia-Pacific

  • In 2021, Asia-Pacific segment accounted for US$6.62 Bn and is expected grow with a CAGR of 4.22% over the forecast years.
  • In Asia-Pacific, China accounted for US$2.49 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Japan accounted for US$1.80 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • India accounted for US$0.86 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Southeast Asia accounted for US$0.80 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Australia & New Zealand accounted for US$0.40 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Rest of Asia-Pacific accounted for US$0.27 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Asia-Pacific Antacids Market, By Country, 2019-2027 (USD billion)
Asia-Pacific Antacids Market, By Country, 2019-2027 (USD billion)
Asia-Pacific Antacids Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Asia-Pacific Antacids Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Revenue Share (%), By Formulation Type - Asia-Pacific (2021)
Revenue Share (%), By Formulation Type - Asia-Pacific (2021)
Revenue Share (%), By Distribution Channel - Asia-Pacific (2021)
Revenue Share (%), By Distribution Channel - Asia-Pacific (2021)
Asia-Pacific Antacids Market, By Country, 2019-2027 (USD billion)
Asia-Pacific Antacids Market, By Country, 2019-2027 (USD billion)
China Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
China Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
China Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
China Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Japan Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Japan Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Japan Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Japan Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
India Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
India Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
India Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
India Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Southeast Asia Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Southeast Asia Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Southeast Asia Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Southeast Asia Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Australia & New Zealand Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Australia & New Zealand Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Australia & New Zealand Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Australia & New Zealand Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Rest of Asia-Pacific Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Rest of Asia-Pacific Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Rest of Asia-Pacific Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Rest of Asia-Pacific Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
08

Middle East & Africa

Based on the Middle East & Africa, the Antacids Market analysis covers Middle East, Africa, Rest of Middle East & Africa.

Middle East & Africa Map
Middle East & Africa Antacids Market Size, 2019-2027 (Us$ Mn)
Middle East & Africa Antacids Size, 2019-2027 (Us$ Mn)
Middle East & Africa Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Middle East & Africa Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Middle East & Africa Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Middle East & Africa Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Middle East Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Middle East Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Middle East Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Middle East Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Africa Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Africa Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Africa Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Africa Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Rest of Middle East & Africa Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Rest of Middle East & Africa Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Rest of Middle East & Africa Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Rest of Middle East & Africa Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
09

Latin America

  • In 2021, Latin America segment accounted for US$6.62 Bn and is expected grow with a CAGR of 4.22% over the forecast years.
  • In Latin America, Brazil accounted for US$2.85 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Argentina accounted for US$1.82 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Mexico accounted for US$1.00 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Colombia accounted for US$0.45 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Rest of Latin America accounted for US$0.49 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Latin America Antacids Market, By Country, 2019-2027 (USD billion)
Latin America Antacids Market, By Country, 2019-2027 (USD billion)
Latin America Antacids Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Latin America Antacids Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Revenue Share (%), By Formulation Type - Latin America (2021)
Revenue Share (%), By Formulation Type - Latin America (2021)
Revenue Share (%), By Distribution Channel - Latin America (2021)
Revenue Share (%), By Distribution Channel - Latin America (2021)
Latin America Antacids Market, By Country, 2019-2027 (USD billion)
Latin America Antacids Market, By Country, 2019-2027 (USD billion)
Brazil Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Brazil Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Brazil Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Brazil Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Argentina Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Argentina Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Argentina Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Argentina Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Mexico Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Mexico Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Mexico Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Mexico Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Colombia Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Colombia Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Colombia Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Colombia Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Rest of Latin America Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Rest of Latin America Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Formulation Type, 2019-2027
Rest of Latin America Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
Rest of Latin America Antacids Market - Historical, Forecast Market Sizes (US$ MN), By Distribution Channel, 2019-2027
10

Company Analysis

  • Bayer AG
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Sun Pharmaceuticals Ltd
  • Sanofi S.A
  • WellSpring Pharmaceutical Corporation
  • Advance Pharmaceutical Inc.
  • CVS Pharmacy
  • Safetec of America, Inc.
  • Pfizer inc.
  • Boehringer Ingelheim International GmbH
  • Dr. Reddy's Laboratories Ltd.
  • Reckitt Benckiser Group plc.
  • Takeda Pharmaceutical Company Limited
  • Procter & Gamble